IRS - Holbæk Sygehus

Medicin og biovidenskab

1. Acetaminophen 15%
2. Anti-Bacterial Agents 11%
3. Antihypertensive Agents 12%
4. Aortic Valve Stenosis 15%
5. Atrial Fibrillation 22%
6. Atrial Flutter 10%
7. Biomarkers 27%
8. Blood Pressure 67%
9. Bone and Bones 13%
10. Bone Density 13%
11. Brain Natriuretic Peptide 17%
12. Cardiac Arrhythmias 10%
13. Cardiac Rehabilitation 25%
14. Cardiology 12%
15. Cardiovascular Diseases 46%
16. Child 14%
17. Chronic Hepatitis B 15%
18. Clarithromycin 12%
19. Clavicle 12%
20. Clinical Trials 17%
21. Cohort Studies 58%
22. Confidence Intervals 41%
23. Coronary Artery Disease 23%
24. Coronary Disease 19%
25. Coronary Vessels 15%
26. Critical Care 22%
27. Critical Illness 28%
28. Data Analysis 13%
29. Databases 18%
30. Delirium 19%
31. Denmark 61%
32. Denosumab 12%
33. Dexmedetomidine 10%
34. Diphosphonates 24%
35. Early Warning Score 34%
36. Elderly 13%
37. Equipment and Supplies 11%
38. Extremely Premature Infants 11%
39. Ezetimibe 13%
40. Glucose 15%
41. Glucose Tolerance Test 13%
42. Guidelines 23%
43. Health 23%
44. Heart 11%
45. Heart Failure 29%
46. Hepatitis B 13%
47. Hip 14%
48. Hip Fractures 47%
49. Hypertension 51%
50. Hypothermia 14%
51. Ibuprofen 15%
52. Incidence 12%
53. Induced Hypothermia 12%
54. Intensive Care Units 17%
55. Interviews 11%
56. Ivabradine 12%
57. MEDLINE 10%
58. Meta-Analysis 98%
59. Middle Aged 11%
60. Morbidity 23%
61. Mortality 88%
62. Multicenter Studies 15%
63. Myocardial Infarction 19%
64. Myocardial Ischemia 20%
65. Neonatal Sepsis 10%
66. Nepal 31%
67. Norway 13%
68. Nurses 32%
69. Observational Studies 13%
70. Odds Ratio 22%
71. Osteogenesis Imperfecta 16%
72. Osteoporosis 46%
73. Osteoporotic Fractures 23%
74. Out-of-Hospital Cardiac Arrest 15%
75. Pain 11%
76. Palliative Care 10%
77. Patient Care 12%
78. Pharmaceutical Preparations 15%
79. Placebos 41%
80. Polycystic Ovary Syndrome 18%
81. Population 37%
82. Prospective Studies 13%
83. Proton Pump Inhibitors 13%
84. Quality of Life 27%
85. Randomized Controlled Trials 91%
86. Registries 25%
87. Research Personnel 12%
88. Risk Assessment 14%
89. Safety 12%
90. Sepsis 14%
91. Serum 13%
92. Sildenafil Citrate 10%
93. Simvastatin 11%
94. Stroke 11%
95. Systematic Reviews 100%
96. Therapeutics 36%
97. Type 2 Diabetes Mellitus 44%
98. Urokinase Plasminogen Activator Receptors 24%
99. Vitamin D 15%
100. Zoledronic Acid 10%